Meropenem and Lincomycin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Meropenem (meropenem) and Lincomycin (lincomycin hydrochloride). Common drug interactions include drug resistance among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Meropenem and Lincomycin. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Meropenem?
Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.
What is Lincomycin?
Lincomycin has active ingredients of lincomycin hydrochloride. eHealthMe is studying from 327 Lincomycin users. Check the latest studies of Lincomycin.
38 people who take Meropenem and Lincomycin together, and have interactions are studied.

What are the common drug interactions of Meropenem and Lincomycin, by gender? *:
female:
- Drug resistance (reduction in effectiveness of a drug)
- Renal impairment (severely reduced kidney function)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Drug ineffective
- Hyperthermia (body temperature greatly above normal)
male:
- Drug ineffective
- Disease progression
- Acidosis hyperchloraemic (increased acidity in the blood and other body tissue with decrease in plasma bicarbonate concentration)
- Hypokalaemia (low potassium)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Nephropathy toxic (damage to kidney due to toxins)
What are the common drug interactions of Meropenem and Lincomycin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Drug ineffective
10-19:
- Drug ineffective
20-29:
- Drug resistance (reduction in effectiveness of a drug)
- Renal impairment (severely reduced kidney function)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Drug ineffective
30-39:
n/a
40-49:
- Hyperthermia (body temperature greatly above normal)
50-59:
- Acidosis hyperchloraemic (increased acidity in the blood and other body tissue with decrease in plasma bicarbonate concentration)
- Hypokalaemia (low potassium)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Nephropathy toxic (damage to kidney due to toxins)
60+:
- Disease progression
- Drug ineffective
What are the existing conditions these people have? *
- Burkholderia Pseudomallei Infection (infection caused by group of bacteria burkholderia pseudomallei): 17 people, 44.74%
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 8 people, 21.05%
- Septic Shock (shock due to blood infection): 8 people, 21.05%
- Necrotising Fasciitis (an uncommon life-threatening soft-tissue infection): 3 people, 7.89%
- Corynebacterium Infection (infection by corynebacterium (diphtheria)): 3 people, 7.89%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 5.26%
- Joint Pain: 2 people, 5.26%
- Intracranial Pressure Increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid): 2 people, 5.26%
- Gout (uric acid crystals building up in the body): 2 people, 5.26%
- Diphtheria (upper respiratory tract illness caused by corynebacterium diphtheriae): 2 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Meropenem and Lincomycin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Meropenem (33,295 reports)
- Lincomycin (327 reports)
Browse all drug interactions of Meropenem and Lincomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lincomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meropenem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lincomycin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on meropenem and lincomycin hydrochloride (the active ingredients of Meropenem and Lincomycin, respectively), and Meropenem and Lincomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amvaz vs. Tamsulosin, side effect and effectiveness comparison - 8 seconds ago
- Ill-Defined Disorder and Tendon Pain - 17 seconds ago
- Could Invokamet cause Chronic Kidney Disease? - 28 seconds ago
- Could Tacrolimus cause Citrobacter Infection? - 31 seconds ago
- Could Tacrolimus cause Bradycardia? - 33 seconds ago
- Could Decadron cause Primary Myelofibrosis? - 33 seconds ago
- Could Elelyso cause Pain? - 37 seconds ago
- Multiple Allergies and Back Pain - 47 seconds ago
- Could Cannabis cause Blood Test Abnormal? - a minute ago
- Drug interactions of Fintepla and Valium - a minute ago